Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 101961
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.101961
Table 2 Patient survival and graft survival log-rank testing between the different body mass index categories
Graft survival pairwise log rank testing
Underweight (< 5th)
Healthy weight (5th-85th)
Overweight (85th-95th)
Class 1 obese (95th-120%95th)
Class 2 obese (120%-140%95th)
Class 3 obese (> 140%95th)
Underweight (< 5th)0.2790.9530.4690.1190.099
Healthy weight (5th-85th)0.2790.2460.7960.0130.022
Overweight (85th-95th)0.9530.2460.4480.0990.055
Class 1 obese (95th-120%95th)0.4690.7960.4480.0330.033
Class 2 obese (120%-140%95th)0.1190.0130.0990.0330.540
Class 3 Obese (> 140%95th)0.0990.0220.0550.0330.540
Patient survival pairwise log rank testing
Underweight (< 5th)0.0070.0260.3160.7790.013
Healthy Weight (5th-85th)0.0070.8450.1790.03< 0.001
Overweight (85th-95th)0.0260.8450.3010.039< 0.001
Class 1 obese (95th-120%95th)0.3160.1790.3010.2350.002
Class 2 obese (120%-140%95th)0.7790.030.0390.2350.063
Class 3 obese (> 140%95th)0.013< 0.001< 0.0010.0020.063